InStar Technologies
InStar Technologies is a biopharmaceutical company specializing in innovative oromucosal drug delivery solutions through their patented InStrip Technology. They focus on developing products that address unmet therapeutic needs, utilizing high barrier technology, and providing comprehensive lifecycle management. Their mission is to revolutionize healthcare by enabling needle-free, efficient, and versatile delivery of peptides, proteins, vaccines, and other active substances via oral thin films, suitable for both human and veterinary use.
Industries
Nr. of Employees
small (1-50)
Products
Oral thin film cannabidiol formulation (example product)
Oral thin film formulation delivering cannabidiol via oromucosal route, designed for rapid onset and dose reduction compared with traditional oral dosing.
Oral thin film cannabidiol formulation (example product)
Oral thin film formulation delivering cannabidiol via oromucosal route, designed for rapid onset and dose reduction compared with traditional oral dosing.
Services
GMP manufacturing of oromucosal oral thin films
Contract manufacturing of oral thin films under GMP for pharmaceutical and veterinary use, including multi-layer nanofiber films and production at varying batch sizes.
R&D product development and formulation
Collaborative formulation and development of nutraceutical and pharmaceutical OTF products (small molecules, peptides, proteins), including feasibility studies and controlled-release design.
Clinical and regulatory support via partner network
Coordination of preclinical and clinical studies and preparation of regulatory dossiers through cooperation with certified external laboratories and clinical sites.
GMP manufacturing of oromucosal oral thin films
Contract manufacturing of oral thin films under GMP for pharmaceutical and veterinary use, including multi-layer nanofiber films and production at varying batch sizes.
R&D product development and formulation
Collaborative formulation and development of nutraceutical and pharmaceutical OTF products (small molecules, peptides, proteins), including feasibility studies and controlled-release design.
Clinical and regulatory support via partner network
Coordination of preclinical and clinical studies and preparation of regulatory dossiers through cooperation with certified external laboratories and clinical sites.
Expertise Areas
- Oromucosal drug delivery
- Oral thin film (OTF) formulation
- Peptide and protein formulation for non-invasive delivery
- Mucosal vaccine delivery
Key Technologies
- Oral thin film (OTF) platforms
- Nanofiber multilayer deposition
- Mucoadhesive formulation technology
- Pharmaceutical polymers for tunable release